Attached files

file filename
EX-10.40 - AMENDMENT TO EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT BY AND BETWEEN WIZE - Mawson Infrastructure Group Inc.f10k2020ex10-40_wizepharma.htm
EX-32.2 - CERTIFICATION - Mawson Infrastructure Group Inc.f10k2020ex32-2_wizepharma.htm
EX-32.1 - CERTIFICATION - Mawson Infrastructure Group Inc.f10k2020ex32-1_wizepharma.htm
EX-31.2 - CERTIFICATION - Mawson Infrastructure Group Inc.f10k2020ex31-2_wizepharma.htm
EX-31.1 - CERTIFICATION - Mawson Infrastructure Group Inc.f10k2020ex31-1_wizepharma.htm
EX-21.1 - SUBSIDIARIES OF THE COMPANY - Mawson Infrastructure Group Inc.f10k2020ex21-1_wizepharma.htm
EX-4.2 - DESCRIPTION OF SECURITIES - Mawson Infrastructure Group Inc.f10k2020ex4-2_wizepharma.htm
10-K - ANNUAL REPORT - Mawson Infrastructure Group Inc.f10k2020_wizepharmainc.htm

EXHIBIT 23.1

Fahn Kanne & Co.

Head Office

32 Hamasger Street

Tel-Aviv 6721118, ISRAEL

PO Box 36172, 6136101

 

T +972 3 7106666

F +972 3 7106660

www.gtfk.co.il

  

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 1, 2021, with respect to the consolidated financial statements included in the Annual Report of Wize Pharma, Inc. on Form 10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said report in the Registration Statement of Wize Pharma, Inc. on Form S-8 (File No. 333-224146).

 

/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

Tel Aviv, Israel

March 1, 2021

 

Certified Public Accountants

Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd.

 

 1